<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4152292</article-id><article-id pub-id-type="pmid">25180686</article-id><article-id pub-id-type="publisher-id">PONE-D-14-12383</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0106534</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Evolutionary Processes</subject><subj-group><subject>Evolutionary Emergence</subject></subj-group></subj-group></subj-group><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Coronaviruses</subject><subj-group><subject>Canine Coronavirus</subject><subject>Feline Coronavirus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Veterinary Science</subject><subj-group><subject>Veterinary Diseases</subject><subj-group><subject>Veterinary Virology</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>Emergence of Pathogenic Coronaviruses in Cats by Homologous Recombination between Feline and Canine Coronaviruses </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head">Emergence of Pathogenic Coronaviruses by Homologous Recombination</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Terada</surname><given-names>Yutaka</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Matsui</surname><given-names>Nobutaka</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Noguchi</surname><given-names>Keita</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kuwata</surname><given-names>Ryusei</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Shimoda</surname><given-names>Hiroshi</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Soma</surname><given-names>Takehisa</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mochizuki</surname><given-names>Masami</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Maeda</surname><given-names>Ken</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Laboratory of Veterinary Microbiology, Joint Faculty of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Veterinary Diagnostic Laboratory, Marupi Lifetech Co. Ltd., Osaka, Japan</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Laboratory of Emerging Infectious Diseases, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Thiel</surname><given-names>Volker</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Berne, Switzerland</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>kmaeda@yamaguchi-u.ac.jp</email></corresp><fn fn-type="COI-statement"><p><text><SENT sid="1" pm="."><plain>Competing Interests: The authors have declared that no competing interests exist. </plain></SENT>
</text></p></fn><fn fn-type="con"><p><text><SENT sid="2" pm="."><plain>Conceived and designed the experiments: KM. </plain></SENT>
<SENT sid="3" pm="."><plain>Performed the experiments: YT NM KN RK HS TS MM KM. </plain></SENT>
<SENT sid="4" pm="."><plain>Analyzed the data: YT KM. </plain></SENT>
<SENT sid="5" pm="."><plain>Contributed reagents/materials/analysis tools: MM TS KM. </plain></SENT>
<SENT sid="6" pm="."><plain>Contributed to the writing of the manuscript: YT NM KM. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>2</day><month>9</month><year>2014</year></pub-date><volume>9</volume><issue>9</issue><elocation-id>e106534</elocation-id><history><date date-type="received"><day>20</day><month>3</month><year>2014</year></date><date date-type="accepted"><day>30</day><month>7</month><year>2014</year></date></history><permissions><copyright-statement>© 2014 Terada et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Terada et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="7" pm="."><plain>Type II feline coronavirus (FCoV) emerged via double recombination between type I FCoV and type II canine coronavirus (CCoV). </plain></SENT>
<SENT sid="8" pm="."><plain>In this study, two type I FCoVs, three type II FCoVs and ten type II CCoVs were genetically compared. </plain></SENT>
<SENT sid="9" pm="."><plain>The results showed that three Japanese type II FCoVs, M91-267, KUK-H/L and Tokyo/cat/130627, also emerged by homologous recombination between type I FCoV and type II CCoV and their parent viruses were genetically different from one another. </plain></SENT>
<SENT sid="10" pm="."><plain>In addition, the 3′-terminal recombination sites of M91-267, KUK-H/L and Tokyo/cat/130627 were different from one another within the genes encoding membrane and spike proteins, and the 5′-terminal recombination sites were also located at different regions of ORF1. </plain></SENT>
<SENT sid="11" pm="."><plain>These results indicate that at least three Japanese type II FCoVs emerged independently. </plain></SENT>
<SENT sid="12" pm="."><plain>Sera from a cat experimentally infected with type I FCoV was unable to neutralize type II CCoV infection, indicating that cats persistently infected with type I FCoV may be superinfected with type II CCoV. </plain></SENT>
<SENT sid="13" pm="."><plain>Our previous study reported that few Japanese cats have antibody against type II FCoV. </plain></SENT>
<SENT sid="14" pm="."><plain>All of these observations suggest that type II FCoV emerged inside the cat body and is unable to readily spread among cats, indicating that these recombination events for emergence of pathogenic coronaviruses occur frequently. </plain></SENT>
</text></SecTag></p></abstract><funding-group><funding-statement>This work was supported by KAKENHI Grant Number 24658257. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="10"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>The authors confirm that all data underlying the findings are fully available without restriction. All nucleotide sequences were deposited to the DNA database of Japan (DDBJ). AB781791, AB907625, AB907626, AB907627, AB907628, AB907629, AB907631, AB907630, AB907632, AB907633, AB781792, AB781793, AB907634, AB781794, AB781795, AB781790, AB781788, AB781789, AB781807, AB781808, AB781809, AB781810, AB781811, AB781812, AB781813, AB781814, AB781815, AB907624, AB781797, AB781798, AB781799, AB781800, AB781801, AB781802, AB781803, AB781804, AB781805, AB781788, AB781789, AB907624, AB781806.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>The authors confirm that all data underlying the findings are fully available without restriction. All nucleotide sequences were deposited to the DNA database of Japan (DDBJ). AB781791, AB907625, AB907626, AB907627, AB907628, AB907629, AB907631, AB907630, AB907632, AB907633, AB781792, AB781793, AB907634, AB781794, AB781795, AB781790, AB781788, AB781789, AB781807, AB781808, AB781809, AB781810, AB781811, AB781812, AB781813, AB781814, AB781815, AB907624, AB781797, AB781798, AB781799, AB781800, AB781801, AB781802, AB781803, AB781804, AB781805, AB781788, AB781789, AB907624, AB781806.</p></notes></front><body><SecTag type="INTRO"><sec id="s1"><title><text><SENT sid="15" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="16" pm="."><plain>Coronaviruses (CoVs) (order Nidovirales, family Coronaviridae, subfamily Coronavirinae) are enveloped and have large single-stranded, positive-sense RNA. </plain></SENT>
<SENT sid="17" pm="."><plain>Most CoVs cause enteric and/or respiratory diseases in mammals and birds. </plain></SENT>
<SENT sid="18" pm="."><plain>The 5′ two-thirds of the CoV genome consists of two overlapping open reading frames (ORFs 1a and 1b) that encode a non-structural polyprotein, including RNA-dependent RNA polymerase (RdRp). </plain></SENT>
<SENT sid="19" pm="."><plain>The other third of the genome consists of ORFs encoding structural proteins, spike (S), membrane (M), envelope (E) and the nucleocapsid (N), and some non-structural proteins (nsp), 3a, 3b, 3c, 7a and 7b [1]. </plain></SENT>
<SENT sid="20" pm="."><plain>Transcription regulatory sequences (TRS) are located at 5′-distal position in each mRNA and play an important role in the RNA replication of CoV [2], [3]. </plain></SENT>
</text></p><p><text><SENT sid="21" pm="."><plain>CoVs frequently undergo mutation and recombination, and there are three reasons for this [4]. </plain></SENT>
<SENT sid="22" pm="."><plain>First, CoV RdRp has low fidelity. </plain></SENT>
<SENT sid="23" pm="."><plain>Although CoV encodes nsp14, which possesses 3′→5′ exonuclease activity for proofreading, the mutation rate approaches 2.0×10−6 mutations per site per round of replication [5]. </plain></SENT>
<SENT sid="24" pm="."><plain>Second, there is a unique RNA replication mechanism using the TRS motif that is known as the “copy choice” mechanism, which induces homologous RNA recombination in CoVs [3], [6]. </plain></SENT>
<SENT sid="25" pm="."><plain>Third, CoV possesses the largest genome (26–32 kb) among RNA viruses. </plain></SENT>
<SENT sid="26" pm="."><plain>Furthermore, heterologous recombination that Betacoronavirus subgroup A has the hemagglutinin esterase gene originated from influenza C virus [7], [8]. </plain></SENT>
<SENT sid="27" pm="."><plain>These mutation and/or recombination events change viral properties, host range and pathogenicity. </plain></SENT>
</text></p><p><text><SENT sid="28" pm="."><plain>Feline CoV (FCoV) is classified into genus Alphacoronavirus, species Alphacoronavirus 1, and includes canine CoV (CCoV), transmissible gastroenteritis virus (TGEV) and porcine respiratory CoV (PRCoV). </plain></SENT>
<SENT sid="29" pm="."><plain>FCoV is distributed worldwide in cats and mainly induces mild intestinal inflammation in kittens [9]. </plain></SENT>
<SENT sid="30" pm="."><plain>FCoV inducing enteric disease is known as feline enteric coronavirus (FECV). </plain></SENT>
<SENT sid="31" pm="."><plain>On the other hand, cats infected with FCoV rarely develop the more severe disease feline infectious peritonitis (FIP), which is caused by a mutant virus that is referred to as FIP virus (FIPV). </plain></SENT>
<SENT sid="32" pm="."><plain>In addition, FCoVs can be divided into two serotypes, types I and II, based on antigenicity [10]–[12]. </plain></SENT>
<SENT sid="33" pm="."><plain>These serotypes differ primarily in growth characteristics in cell culture and in receptor usage. </plain></SENT>
<SENT sid="34" pm="."><plain>Type II FCoV is able to use feline aminopeptidase N (fAPN) as its receptor, but type I FCoV cannot [9], [13]. </plain></SENT>
<SENT sid="35" pm="."><plain>Recently, it was revealed that the S protein was solely responsible for the differences in types I and II FCoV with regard to growth characteristics in cell culture and fAPN usage [14]. </plain></SENT>
</text></p><p><text><SENT sid="36" pm="."><plain>CCoV was first isolated in 1971 from dogs with moderate to severe enteritis in Germany [15]. </plain></SENT>
<SENT sid="37" pm="."><plain>CCoV is widespread in the dog population and is one of the most important canine enteropathogens [16]–[22]. </plain></SENT>
<SENT sid="38" pm="."><plain>CCoVs were also divided into two genotypes; I and II. </plain></SENT>
<SENT sid="39" pm="."><plain>Before 2000, it was thought that CCoV had only one genotype, but strain Elmo/02 with a type I FCoV-like S gene was detected in Italy [23]. </plain></SENT>
<SENT sid="40" pm="."><plain>The Elmo/02 strain possessed a novel ORF3 gene that was absent from other Alphacoronavirus 1 between the S and ORF3a genes [24]. </plain></SENT>
<SENT sid="41" pm="."><plain>Finally, this type I FCoV like-CCoV was designated type I CCoV and the reference CCoV was designated type II CCoV. </plain></SENT>
<SENT sid="42" pm="."><plain>Surprisingly, 36.9%–76.8% of dogs with diarrhea were co-infected with both types I and II CCoV [25]–[27]. </plain></SENT>
<SENT sid="43" pm="."><plain>Furthermore, type II CCoV was divided into two subtypes, IIa and IIb [28]. </plain></SENT>
<SENT sid="44" pm="."><plain>In type IIb CCoV, the 5′-terminal region of the S gene was similar to that of TGEV and it was thought that type IIb CCoV emerged via recombination between type IIa CCoV and TGEV [28]. </plain></SENT>
<SENT sid="45" pm="."><plain>Recently, a type IIa CCoV strain CB/05 with high virulence was reported in Europe [29]. </plain></SENT>
<SENT sid="46" pm="."><plain>CB/05-infected pups showed clinical signs such as lethargy, vomiting, diarrhea and acute lymphopenia, and the viral genome was observed in extraintestinal tissues including brain [29], [30]. </plain></SENT>
<SENT sid="47" pm="."><plain>Furthermore, immune response induced by enteric CCoV did not protect dogs from infection with CB/05 [31]. </plain></SENT>
<SENT sid="48" pm="."><plain>However, there is little genetic information on CCoV in Japan. </plain></SENT>
</text></p><p><text><SENT sid="49" pm="."><plain>In this study, to clarify the mechanisms of emergence of type II FCoV, three type II FCoVs isolated in Japan were genetically and antigenetically compared with ten Japanese type II CCoVs and two Japanese type I FCoVs. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods" id="s2"><title><text><SENT sid="50" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><p><text><SENT sid="51" pm="."><plain>All animal procedures were conducted according to the Yamaguchi University Animal Care and Use guidelines and were approved by the Institutional Animal Care and Use Committee of Yamaguchi University. </plain></SENT>
<SENT sid="52" pm="."><plain>All efforts were made to minimize pain and suffering. </plain></SENT>
</text></p><sec id="s2a"><title><text><SENT sid="53" pm="."><plain>Cells </plain></SENT>
</text></title><p><text><SENT sid="54" pm="."><plain>Felis catus whole fetus-4 cells (fcwf-4 cells; ATCC Number: CRL-2787) [32] were grown in Dulbecco's modified Eagle's medium (DMEM; Life Technologies, Carlsbad, CA) containing 10% fetal calf serum (FCS), 100 U/ml penicillin and 100 µg/ml streptomycin (Life Technologies). </plain></SENT>
<SENT sid="55" pm="."><plain>Cells were maintained in a humidified 5% CO2 incubator at 37°C. </plain></SENT>
</text></p></sec><sec id="s2b"><title><text><SENT sid="56" pm="."><plain>Viruses </plain></SENT>
</text></title><p><text><SENT sid="57" pm="."><plain>Type I FCoV strains C3663 and Yayoi, type II FCoV strains M91-267, KUK-H/L and Tokyo/cat/130627 and type II CCoV strains fc1, fc4, fc7, fc9, fc76, fc100, fc94-039, fc97-022, fc00-089 and fc00-016 were analyzed in this study (Table 1). </plain></SENT>
<SENT sid="58" pm="."><plain>Type I and II FCoVs, excluding Tokyo/cat/130627, were characterized by indirect fluorescence assay (IFA) using monoclonal antibodies (MAbs) that were kindly provided by Dr. Hohdatsu [11], [33]. </plain></SENT>
<SENT sid="59" pm="."><plain>Yayoi strain was isolated from a cat with a non-effusive form of FIP in Tokyo by serial passage in suckling mouse brain, and was then adapted to fcwf-4 cells [34]. </plain></SENT>
<SENT sid="60" pm="."><plain>C3663 strain was isolated from a cat with an effusive form of FIP in Kagoshima in 1994 [35]. </plain></SENT>
<SENT sid="61" pm="."><plain>The pathogenicity of C3663 and Yayoi in cats was characterized [36]. </plain></SENT>
<SENT sid="62" pm="."><plain>M91-267 strain was isolated from a cat with an effusive form of FIP in Miyazaki in 1991 [35]. </plain></SENT>
<SENT sid="63" pm="."><plain>Three SPF cats were experimentally infected with M91-267, and all of these died from FIP (unpublished data). </plain></SENT>
<SENT sid="64" pm="."><plain>KUK-H strain was isolated from a cat with an effusive form of FIP in Kagoshima in 1987, and KUK-H/L that formed large plaques was plaque-purified from the KUK-H strain [35]. </plain></SENT>
<SENT sid="65" pm="."><plain>KUK-H/L caused lethal FIP in cats [35]. </plain></SENT>
<SENT sid="66" pm="."><plain>RNA sequences of Tokyo/cat/130627 were obtained from FIP ascites in a cat in Tokyo in 2013. </plain></SENT>
<SENT sid="67" pm="."><plain>The FIPV spread quickly in a cattery, and more than twenty cats developed FIP. </plain></SENT>
<SENT sid="68" pm="."><plain>Type II CCoV strains, fc1, fc4, fc7, fc9, fc76, fc100, fc94-039 and fc97-022, were isolated between 1990 and 1997 in Japan [19], and fc00-016 and fc00-087 were isolated in 2000 in Japan [37]. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0106534-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106534.t001</object-id><label>Table 1</label><caption><title><text><SENT sid="69" pm="."><plain>Canine and feline coronaviruses analyzed in this study: nucleotide sequence acquisition numbers and serum cross-neutralizing activity. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0106534-t001-1" xlink:href="pone.0106534.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="70" pm="."><plain>Virus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="71" pm="."><plain>Strain </plain></SENT>
</text></td><td colspan="4" align="left" rowspan="1"><text><SENT sid="72" pm="."><plain>Accession No. </plain></SENT>
</text></td><td colspan="2" align="left" rowspan="1"><text><SENT sid="73" pm="."><plain>VN titers </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="74" pm="."><plain>RdRp </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="75" pm="."><plain>S - poly A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="76" pm="."><plain>Partial S </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="77" pm="."><plain>N </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="78" pm="."><plain>Type Ia </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="79" pm="."><plain>Type IIb </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="80" pm="."><plain>Type II CCoV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="81" pm="."><plain>fc1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="82" pm="."><plain>AB781791 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="83" pm="."><plain>AB781790 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="84" pm="."><plain>AB781790 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="85" pm="."><plain>AB781790 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="86" pm="."><plain>&lt;1∶10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="87" pm="."><plain>1∶400 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="88" pm="."><plain>fc4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="89" pm="."><plain>AB907625 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="90" pm="."><plain>AB781807 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="91" pm="."><plain>AB781797 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="92" pm="."><plain>&lt;1∶10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="93" pm="."><plain>1∶4525 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="94" pm="."><plain>fc7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="95" pm="."><plain>AB907626 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="96" pm="."><plain>AB781808 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="97" pm="."><plain>AB781798 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="98" pm="."><plain>&lt;1∶10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="99" pm="."><plain>1∶1600 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="100" pm="."><plain>fc9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="101" pm="."><plain>AB907627 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="102" pm="."><plain>AB781809 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="103" pm="."><plain>AB781799 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="104" pm="."><plain>&lt;1∶10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="105" pm="."><plain>1∶1600 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="106" pm="."><plain>fc76 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="107" pm="."><plain>AB907628 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="108" pm="."><plain>AB781810 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="109" pm="."><plain>AB781800 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="110" pm="."><plain>&lt;1∶10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="111" pm="."><plain>1∶9051 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="112" pm="."><plain>fc100 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="113" pm="."><plain>AB907629 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="114" pm="."><plain>AB781811 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="115" pm="."><plain>AB781801 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="116" pm="."><plain>&lt;1∶10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="117" pm="."><plain>1∶1131 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="118" pm="."><plain>fc97-022 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="119" pm="."><plain>AB907631 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="120" pm="."><plain>AB781812 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="121" pm="."><plain>AB781802 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="122" pm="."><plain>&lt;1∶10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="123" pm="."><plain>1∶2263 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="124" pm="."><plain>fc94-039 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="125" pm="."><plain>AB907630 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="126" pm="."><plain>AB781813 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="127" pm="."><plain>AB781803 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="128" pm="."><plain>&lt;1∶10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="129" pm="."><plain>1∶2263 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="130" pm="."><plain>fc00-016 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="131" pm="."><plain>AB907632 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="132" pm="."><plain>AB781814 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="133" pm="."><plain>AB781804 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="134" pm="."><plain>&lt;1∶10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="135" pm="."><plain>1∶1600 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="136" pm="."><plain>fc00-089 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="137" pm="."><plain>AB907633 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="138" pm="."><plain>AB781815 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="139" pm="."><plain>AB781805 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="140" pm="."><plain>&lt;1∶10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="141" pm="."><plain>1∶200 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="142" pm="."><plain>Type II FCoV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="143" pm="."><plain>M91-267 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="144" pm="."><plain>AB781792 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="145" pm="."><plain>AB781788 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="146" pm="."><plain>AB781788 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="147" pm="."><plain>AB781788 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="148" pm="."><plain>&lt;1∶10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="149" pm="."><plain>1∶25600 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="150" pm="."><plain>KUK-H/L </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="151" pm="."><plain>AB781793 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="152" pm="."><plain>AB781789 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="153" pm="."><plain>AB781789 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="154" pm="."><plain>AB781789 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="155" pm="."><plain>&lt;1∶10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="156" pm="."><plain>1∶6400 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="157" pm="."><plain>Tokyo/cat/130627 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="158" pm="."><plain>AB907634 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="159" pm="."><plain>AB907624 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="160" pm="."><plain>AB907624 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="161" pm="."><plain>AB907624 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="162" pm="."><plain>N.D. </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="163" pm="."><plain>N.D. </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="164" pm="."><plain>Type I FCoV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="165" pm="."><plain>C3663 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="166" pm="."><plain>AB781794 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="167" pm="."><plain>AB535528c </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="168" pm="."><plain>AB535528c </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="169" pm="."><plain>AB535528c </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="170" pm="."><plain>1∶6400 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="171" pm="."><plain>1∶80 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="172" pm="."><plain>Yayoi </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="173" pm="."><plain>AB781795 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"><text><SENT sid="174" pm="."><plain>AB695067c </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="175" pm="."><plain>AB781806 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="176" pm="."><plain>1∶2000 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="177" pm="."><plain>1∶160 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p><text><SENT sid="178" pm="."><plain>N.D.: Not done. </plain></SENT>
</text></p></fn><fn id="nt102"><label>a</label><p><text><SENT sid="179" pm="."><plain>Serum was collected from the cat that was inoculated intraorally with type I FCoV C3663 [36]. </plain></SENT>
</text></p></fn><fn id="nt103"><label>b</label><p><text><SENT sid="180" pm="."><plain>Serum was collected from the cat that was inoculated intraperitoneally with type II FCoV M91-267 (unpublished data). </plain></SENT>
</text></p></fn><fn id="nt104"><label>c</label><p><text><SENT sid="181" pm="."><plain>[36]. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec id="s2c"><title><text><SENT sid="182" pm="."><plain>Reverse transcription (RT)-polymerase chain reaction (PCR) </plain></SENT>
</text></title><p><text><SENT sid="183" pm="."><plain>Each virus, excluding Tokyo/cat/130627, was inoculated onto an fcwf-4 cell monolayer and was incubated until cytopathic effects (CPEs) were observed. </plain></SENT>
<SENT sid="184" pm="."><plain>RNA was then extracted from fcwf-4 cells using an RNeasy Mini kit (Qiagen, Hilden, Germany) and RT reaction was carried out at 30°C for 10 min, 42°C for 30 min, 70°C for 15 min and 5°C for 5 min with random 9-mer oligonucleotide primers or 42°C for 30 min, 70°C for 15 min and 5°C for 5 min with oligo dT-adaptor primer using a TaKaRa RNA LA PCR kit (AMV) Ver.1.1 (TaKaRa, Shiga, Japan). </plain></SENT>
</text></p><p><text><SENT sid="185" pm="."><plain>For amplification of partial S genes of type II CCoVs and type II FCoVs, primers CCVSF (5′-AGCACTTTTCCTATTGATTG-3′) and CCVSR (5′-GTTAGTTTGTCTAATAATACCAACACC-3′) were used [38]. </plain></SENT>
<SENT sid="186" pm="."><plain>For amplification of the N gene, primers NF (5′-CTAAAGCTGGTGATTACTCAACAG-3′) and NR (5′-TAATAAATACAGCGTGGAGGAAAAC-3′) were used [39]. </plain></SENT>
<SENT sid="187" pm="."><plain>PCR was carried out at 94°C for 2 min, followed by 40 cycles at 94°C for 30 s, 55°C for 30 s, 72°C for 2 min and final extension at 72°C for 10 min using a TaKaRa RNA LA PCR kit (AMV) Ver.1.1 (TaKaRa). </plain></SENT>
<SENT sid="188" pm="."><plain>PCR products were analyzed electrophoretically and amplified products were purified using a QIAquick PCR Purification kit (Qiagen) for sequence analysis. </plain></SENT>
</text></p><p><text><SENT sid="189" pm="."><plain>In order to amplify the subgenomic mRNA of CCoV fc1, PCR was performed using 52F (5′-ACTAGCCTTGTGCTAGATTT-3′) as a forward primer and CCVScenR (5′-CCAGTTTTTATAACAGCTG-3′), N-RR2 (5′-GCGCAATAACGTTCACCA-3′) and M13 primer M4 as reverse primers. </plain></SENT>
<SENT sid="190" pm="."><plain>Primer 52F recognized the TRS conserved among Alphacoronaviruses [36]. </plain></SENT>
<SENT sid="191" pm="."><plain>The reaction was carried out under the same conditions as mentioned above. </plain></SENT>
</text></p><p><text><SENT sid="192" pm="."><plain>For sequence analysis of ORFs M, N, 7a and 7b of M91-267 and KUK-H/L, we carried out TA cloning. </plain></SENT>
<SENT sid="193" pm="."><plain>RNA was extracted from fcwf-4 cells infected with M91-267 or KUK-H/L using an RNeasy Mini kit (Qiagen). </plain></SENT>
<SENT sid="194" pm="."><plain>Extracted RNA was reverse-transcribed with oligo dT-Adaptor primer using a TaKaRa RNA LA PCR kit (AMV) Ver.1.1 (TaKaRa) as mentioned above. </plain></SENT>
<SENT sid="195" pm="."><plain>To amplify the region including ORFs M, N, 7a and 7b, primers 52F, M13 primer M4 were used for PCR with a TaKaRa RNA LA PCR kit (AMV) Ver.1.1 (TaKaRa). </plain></SENT>
<SENT sid="196" pm="."><plain>PCR products were directly cloned into pGEM-T Easy (Promega, Madison, WI) according to the manufacturer's instructions. </plain></SENT>
<SENT sid="197" pm="."><plain>Plasmid DNAs were extracted from E. coli strain JM109 using a QIAprep Spin Miniprep Kit (Qiagen). </plain></SENT>
<SENT sid="198" pm="."><plain>Purified plasmid DNAs were applied for sequencing analysis. </plain></SENT>
</text></p><p><text><SENT sid="199" pm="."><plain>Viral RNA of Tokyo/cat/130627 was extracted from FIP ascites in a cat using a QIAamp Viral RNA Mini Kit (Qiagen). </plain></SENT>
<SENT sid="200" pm="."><plain>For sequence analysis, five fragments of the Tokyo/cat/130627 gene between the 3′- terminus of ORF 1b and poly A were amplified using the following primer pairs: 1bF (5′-TTGATTCAAAGATTTGAGTATTGG-3′)-CCVSR; CCVSF-S2cenFR3 (5′-GTGTCAATTCAGGTACAG-3′); S2cenFF2 (5′-GAGTGCTGATGCACAAGT-3′)-N-RR3 (5′-GCCACCATACAATGTGAC-3′); N-RF4 (5′- AGTTCAGCATTGCTGTGCTC-3′)-N4 (5′-CATCTCAACCTGTGTGTCAT-3′); and N1 (5′-MMAAYAAACACACCTGGAAG-3′)-oligo dT-Adaptor primer. </plain></SENT>
<SENT sid="201" pm="."><plain>RT-PCR was carried out using a QIAGEN OneStep RT-PCR Kit (Qiagen) according to the manufacturer's instructions. </plain></SENT>
<SENT sid="202" pm="."><plain>Reactions were carried out at 45°C for 45 min and 95°C for 15 min, followed by 40 cycles at 94°C for 10 s, 55°C for 30 s, 68°C for 3 min, and a final extension at 68°C for 15 min. </plain></SENT>
<SENT sid="203" pm="."><plain>For amplification of partial RdRp genes, primer IN-6 (5′- GGTTGGGACTATCCTAAGTGTGA -3′) and IN-7 (5′- CCATCATCAGATAGAATCATCAT -3′) were used as described previously [40]. </plain></SENT>
<SENT sid="204" pm="."><plain>PCR products were analyzed electrophoretically and amplified products were purified using a MinElute PCR Purification Kit (Qiagen) for sequence analysis. </plain></SENT>
</text></p></sec><sec id="s2d"><title><text><SENT sid="205" pm="."><plain>Nucleotide sequences </plain></SENT>
</text></title><p><text><SENT sid="206" pm="."><plain>Sequencing was performed using a BigDye Terminator v3.1 Cycle Sequencing kit (Life Technologies) according to the manufacturer's instructions. </plain></SENT>
<SENT sid="207" pm="."><plain>Products were purified by ethanol precipitation and analyzed using an ABI PRISM 310 Genetic Analyzer (Life Technologies). </plain></SENT>
<SENT sid="208" pm="."><plain>For sequence analysis, primers shown in Table S1 were used and nucleotide sequences were deposited to the DNA database of Japan (DDBJ) under the accession numbers listed in Table 1. </plain></SENT>
</text></p></sec><sec id="s2e"><title><text><SENT sid="209" pm="."><plain>Homology search and phylogenetic analysis </plain></SENT>
</text></title><p><text><SENT sid="210" pm="."><plain>Homologies among strains were analyzed using GENETYX Ver.8 (GENETYX Corporation, Tokyo, Japan) and phylogenetic trees were constructed by the neighbor-joining method [41] using MEGA5.0 software [42] based on nucleotide pairwise distance. </plain></SENT>
<SENT sid="211" pm="."><plain>For construction of the phylogenetic tree, we referred to the following sequences; type II FCoV 79-1146 (accession no. DQ010921), 79-1683 (JN634064), DF-2 (JQ408981) and NTU156/P/2007 (GQ152141), type I FCoV C3663 (AB535528), Yayoi (AB695067 for S), UCD1 (AB088222 for S, AB086902 for N), Black (EU186072), NTU2/R/2003 (DQ160294), RM (FJ938051), UCD11a (FJ917519), UCD5 (FJ917522), UCD12 (FJ917521), UCD13 (FJ917523), UCD14 (FJ917524), UU2 (FJ938060), UU16 (FJ938058), UU18 (HQ012368), UU20 (HQ392471), UU21 (HQ012369), UU23 (GU553362), type II CCoV 1-71 (JQ404409), v1 (AY390342 for S, AY390345 for N), K378 (KC175340), NTU336/F/2008 (GQ477367), 5821 (AB017789 for S), TGEV Purdue (DQ811789), and PRCoV ISU-1 (DQ811787). </plain></SENT>
<SENT sid="212" pm="."><plain>Analysis of the similarity in the 3′-region of the genome, excluding poly A, was carried out using Simplot version 3.5.1 [43]. </plain></SENT>
</text></p></sec><sec id="s2f"><title><text><SENT sid="213" pm="."><plain>Sera from cats </plain></SENT>
</text></title><p><text><SENT sid="214" pm="."><plain>Sera collected from two SPF cats experimentally inoculated with FIPVs were used. </plain></SENT>
<SENT sid="215" pm="."><plain>One cat was inoculated intra-orally with type I FCoV C3663 (3.9×106 PFU/cat) and showed an effusion form of FIP [36]. </plain></SENT>
<SENT sid="216" pm="."><plain>Another cat was inoculated intraperitoneally with type II FCoV M91-267 (1.0×106 PFU/cat) and also showed an effusive form of FIP (unpublished data). </plain></SENT>
<SENT sid="217" pm="."><plain>When clinical symptoms were severe, cats were euthanized under anesthesia. </plain></SENT>
<SENT sid="218" pm="."><plain>These sera were obtained in our previous experiments carried out under approval by the ethics committee for animal experiments, Faculty of Agriculture, Yamaguchi University. </plain></SENT>
</text></p></sec><sec id="s2g"><title><text><SENT sid="219" pm="."><plain>Virus-neutralization test </plain></SENT>
</text></title><p><text><SENT sid="220" pm="."><plain>Virus-neutralization (VN) test was performed by 75% plaque-reduction neutralization test (PRNT75) using cat sera inactivated at 56°C for 30 min [12], [36]. </plain></SENT>
<SENT sid="221" pm="."><plain>Equal volumes of two-fold serially diluted sera and 2.0×103 PFU/ml virus were mixed and incubated at 37°C for 1 h. </plain></SENT>
<SENT sid="222" pm="."><plain>Then, 50 µl of this mixture was inoculated onto an fcwf-4 cell monolayer in 24-well plates (Sumitomo Bakelite, Tokyo, Japan). </plain></SENT>
<SENT sid="223" pm="."><plain>After adsorption at 37°C for 1 h, inoculum was removed and 0.8% agarose (Seaplaque GTG Agarose; Lonza, Switzerland) in DMEM containing 10% FCS was overlaid. </plain></SENT>
<SENT sid="224" pm="."><plain>Infected cells were incubated at 37°C until CPE was observed, followed by fixing with phosphate-buffered formalin and staining with crystal violet. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec id="s3"><title><text><SENT sid="225" pm="."><plain>Results </plain></SENT>
</text></title><sec id="s3a"><title><text><SENT sid="226" pm="."><plain>Comparison of 3′-region among type II CCoVs, and type I and II FCoVs </plain></SENT>
</text></title><p><text><SENT sid="227" pm="."><plain>Nucleotide sequences of the 3′-region of the genomes, excluding the poly A, of type II CCoV fc1 (8,959b) and type II FCoVs, M91-267 (8,889b), KUK-H/L (8,930b) and Tokyo/cat/130627 (8,831b), were determined (DDBJ Accession No. AB781790 for fc1, AB781788 for M91-267, AB781789 for KUK-H/L and AB907624 for Tokyo/cat/130627) (Table1). </plain></SENT>
<SENT sid="228" pm="."><plain>Because of a mutation in the start codon (ATG→ACG), Tokyo/cat/130627 lacked ORF3b. </plain></SENT>
<SENT sid="229" pm="."><plain>In addition, type II FCoVs, M91-267 and Tokyo/cat/130627 possessed a truncated ORF 3c (Fig. 1). </plain></SENT>
<SENT sid="230" pm="."><plain>When compared with KUK-H/L, M91-267 had a 35-nucleotide deletion in the ORF 3c gene, resulting in a truncated ORF 3c. </plain></SENT>
<SENT sid="231" pm="."><plain>In comparison with C3663, Tokyo/cat/130627 showed a 25-nucleotide deletion in the ORF 3c gene, resulting in a truncated ORF 3c gene. </plain></SENT>
<SENT sid="232" pm="."><plain>Deduced amino acid sequences for ORFs S, 3a, 3b, 3c, E, M, N, 7a and 7b in type II FCoVs were compared with those of type I FCoV C3663 and type II CCoV fc1 (Table S2, S3). </plain></SENT>
<SENT sid="233" pm="."><plain>Both M91-267 and KUK-H/L showed low identities with type I FCoV C3663 in ORFs S, 3a, 3b, 3c and E and high identities in ORFs N, 7a and 7b (Table S2). </plain></SENT>
<SENT sid="234" pm="."><plain>In contrast, the two strains showed high identities with type II CCoV fc1 in ORFs S, 3a, 3b, 3c and E and low identities in ORFs N, 7a and 7b (Table S3). </plain></SENT>
<SENT sid="235" pm="."><plain>In ORF M, the identities among type I FCoV, type II FCoV and CCoV were neither high nor low (Table S2, S3). </plain></SENT>
<SENT sid="236" pm="."><plain>Interestingly, comparison between Tokyo/cat/130627 and type I FCoV showed low identities in ORF S and high identities in ORFs 3a, 3c, E, M, N, 7a and 7b, while comparison with type II CCoV fc1 showed high identity only in ORF S and low identities in ORF 3a, 3c, E, M, N, 7a and 7b (Table S2, S3). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0106534-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106534.g001</object-id><label>Figure 1</label><caption><title><text><SENT sid="237" pm="."><plain>Schema of feline and canine coronaviruses. </plain></SENT>
</text></title><p><text><SENT sid="238" pm="."><plain>(A) Schema of type II CCoV. </plain></SENT>
<SENT sid="239" pm="."><plain>Each ORF is indicated by squares. </plain></SENT>
<SENT sid="240" pm="."><plain>Arrowheads indicate location of primers for amplification of partial RdRp, partial S and full N genes. </plain></SENT>
<SENT sid="241" pm="."><plain>(B) Schema of type II CCoV fc1, type II FCoV M91-267, KUK-H/L and Tokyo/cat/130627, and type I FCoV C3663 and Yayoi. </plain></SENT>
<SENT sid="242" pm="."><plain>Blue boxes indicate ORFs originating from type II CCoV. </plain></SENT>
<SENT sid="243" pm="."><plain>Red boxes indicate ORFs originating from type I FCoV. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0106534.g001"/></fig></SecTag></sec><sec id="s3b"><title><text><SENT sid="244" pm="."><plain>Comparison of partial RdRp genes among type II CCoVs and type I and II FCoVs </plain></SENT>
</text></title><p><text><SENT sid="245" pm="."><plain>Nucleotide sequences of partial RdRp gene in ORF1b (394b) of 15 Japanese CoVs were determined and deduced amino acid sequences were compared (Tables S2, S3, S4 and Fig. 2A). </plain></SENT>
<SENT sid="246" pm="."><plain>In comparison with type I FCoVs, C3663, KUK-H/L and Tokyo/cat/130627 showed higher identity in RdRp than M91-267 (Table S2). </plain></SENT>
<SENT sid="247" pm="."><plain>On the other hand, the sequence of RdRp of M91-267 was more similar to that of type II CCoV fc1 than type I FCoV C3663 (Table S3). </plain></SENT>
<SENT sid="248" pm="."><plain>All CCoV strains possessed high homology with fc1 strain and M91-267, but showed low homology with KUK-H/L and Tokyo/cat/130627 (Table S4). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0106534-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106534.g002</object-id><label>Figure 2</label><caption><title><text><SENT sid="249" pm="."><plain>Phylogenetic trees using partial RdRp(A), partial S (B) and N (C) genes. </plain></SENT>
</text></title><p><text><SENT sid="250" pm="."><plain>Type I FCoVs, type II FCoVs and type II CCoVs are shown in red, green and blue, respectively. </plain></SENT>
<SENT sid="251" pm="."><plain>Swine CoV (TGEV and PRCoV), ferret CoV (FRCoV) and human CoV (HCoV) are shown in black. </plain></SENT>
<SENT sid="252" pm="."><plain>GenBank accession numbers are shown in parentheses. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0106534.g002"/></fig></SecTag><p><text><SENT sid="253" pm="."><plain>Phylogenetic analysis using partial RdRp genes showed that Japanese type II strains could be divided into two different groups; feline CoV and canine CoV (Fig. 2A). </plain></SENT>
<SENT sid="254" pm="."><plain>KUK-H/L and Tokyo/cat/130627 belonged to feline CoV group and M91-267 belonged to canine CoV group. </plain></SENT>
<SENT sid="255" pm="."><plain>The other foreign type II FCoVs belonged to the type II CCoV group. </plain></SENT>
</text></p></sec><sec id="s3c"><title><text><SENT sid="256" pm="."><plain>Comparison of partial S genes among type II CCoVs and type I and II FCoVs </plain></SENT>
</text></title><p><text><SENT sid="257" pm="."><plain>Nucleotide sequences of partial S genes (692b) of 15 Japanese CoVs were determined and deduced amino acid sequences were compared (Table S5 and Fig. 2B). </plain></SENT>
<SENT sid="258" pm="."><plain>In comparison with type I FCoV C3663, all type II FCoVs showed low identity. </plain></SENT>
<SENT sid="259" pm="."><plain>All CCoV strains possessed high homology with fc1 strain and type II FCoVs, but showed low homology with type I FCoV C3663 (Table S5). </plain></SENT>
</text></p><p><text><SENT sid="260" pm="."><plain>Phylogenetic analysis using partial S genes showed that all type II FCoVs were more similar to type II CCoV than type I FCoV (Fig.2B). </plain></SENT>
<SENT sid="261" pm="."><plain>Furthermore, Japanese type II FCoVs were more similar to Japanese type II CCoV than type II FCoVs and type II CCoVs from other countries. </plain></SENT>
<SENT sid="262" pm="."><plain>In addition, Japanese FCoVs belonged to different subgroups; KUK-H/L belongs to a cluster with fc1. </plain></SENT>
<SENT sid="263" pm="."><plain>M91-267 belongs to the other cluster with fc76 and fc94-039. </plain></SENT>
<SENT sid="264" pm="."><plain>Tokyo/cat/130627 belongs to the cluster with Taiwanese strain NTU156/P/2007 (Fig. 2B). </plain></SENT>
</text></p></sec><sec id="s3d"><title><text><SENT sid="265" pm="."><plain>Comparison of N genes among type II CCoVs and type I and II FCoVs </plain></SENT>
</text></title><p><text><SENT sid="266" pm="."><plain>Nucleotide sequences of N genes (1149b) of 15 Japanese CoVs were determined and deduced amino acid sequences were compared (Tables S2, S3, S6 and Fig. 2C). </plain></SENT>
<SENT sid="267" pm="."><plain>In comparison with type I FCoV C3663, all type II FCoVs showed higher identity than type II CCoV fc1 (Table S2). </plain></SENT>
<SENT sid="268" pm="."><plain>All CCoV strains possessed high homology with fc1 strain, but showed low homology with types I and II FCoV (Table S6). </plain></SENT>
</text></p><p><text><SENT sid="269" pm="."><plain>Phylogenetic analysis using N genes showed that FCoV strains and type II CCoV strains were genetically divided into different groups. </plain></SENT>
<SENT sid="270" pm="."><plain>In the feline CoV group, Japanese type II FCoVs M91-267, KUK-H/L and Tokyo/cat/130627 belonged to different clusters (Fig. 2C). </plain></SENT>
<SENT sid="271" pm="."><plain>KUK-H/L was similar to Yayoi, M91-267 was similar to C3663, and Tokyo/cat/130627 was similar to Taiwanese strain NTU2/R/2003 (Fig. 2C). </plain></SENT>
<SENT sid="272" pm="."><plain>Japanese CCoVs formed one cluster with Taiwanese strain NTU336/F/2008. </plain></SENT>
</text></p></sec><sec id="s3e"><title><text><SENT sid="273" pm="."><plain>Recombination sites of type II FCoVs </plain></SENT>
</text></title><p><text><SENT sid="274" pm="."><plain>Simplot analysis showed that the similarity of Tokyo/cat/130627 to CCoV fc1 changed at the 3′-terminal region of the S gene, and those of M91-267 and KUK-H/L changed within the M gene (Fig. 3). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0106534-g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106534.g003</object-id><label>Figure 3</label><caption><title><text><SENT sid="275" pm="."><plain>Simplot analysis of canine and feline coronaviruses. </plain></SENT>
</text></title><p><text><SENT sid="276" pm="."><plain>Similarity between nucleotide sequences of 3′-region of genome of type II CCoV fc1, type I FCoV Black, and type II FCoVs KUK-H/L, M91-267 and Tokyo/cat/130627. </plain></SENT>
<SENT sid="277" pm="."><plain>Horizontal axis refers to nucleotide position of fc1. </plain></SENT>
<SENT sid="278" pm="."><plain>Upper region of the plot map shows ORF structure in type II CCoV fc1 and corresponds to nucleotide positions in the plot map. </plain></SENT>
<SENT sid="279" pm="."><plain>A similarity of 1.0 indicates 100% identity with the nucleotide sequence. </plain></SENT>
<SENT sid="280" pm="."><plain>Parameters for calculation were as follows: window size, 200 bp; and step size, 40 bp. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0106534.g003"/></fig></SecTag><p><text><SENT sid="281" pm="."><plain>The M genes were compared among types I and II FCoV and type II CCoV (Fig. 4A). </plain></SENT>
<SENT sid="282" pm="."><plain>The alignment showed that the 5′-terminal region of the M genes of M91-267 and KUK-H/L was similar to that of CCoV fc1, but the 3′-terminal region was similar to type I FCoV C3663 (Fig. 4A). </plain></SENT>
<SENT sid="283" pm="."><plain>The M gene of Tokyo/cat/130627 was similar to type I FCoV C3663. </plain></SENT>
<SENT sid="284" pm="."><plain>Furthermore, the nucleotide sequences indicated that the recombination sites of these two viruses, M91-267 and KUK-H/L, were different. </plain></SENT>
<SENT sid="285" pm="."><plain>Among these CoVs, two conserved regions were located at 133–177 and 325–366 in the M gene. </plain></SENT>
<SENT sid="286" pm="."><plain>KUK-H/L was similar to type II CCoV upstream of the first conserved region (region 133–177), but was similar to type I FCoV downstream of the region. </plain></SENT>
<SENT sid="287" pm="."><plain>On the other hand, M91-267 was similar to type II CCoV upstream of the second conserved region (region 325–366), and was similar to type I FCoV downstream of the region. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0106534-g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106534.g004</object-id><label>Figure 4</label><caption><title><text><SENT sid="288" pm="."><plain>Alignment of M and 3′-terminal of S genes in canine and feline coronaviruses. </plain></SENT>
</text></title><p><text><SENT sid="289" pm="."><plain>(A) Alignment of M genes of CCoV and FCoV strains. </plain></SENT>
<SENT sid="290" pm="."><plain>Two regions in squares are conserved regions among type II CCoV fc1, type II FCoVs M91-267, KUK-H/L and Tokyo/cat/130627 and type I FCoV C3663. </plain></SENT>
<SENT sid="291" pm="."><plain>(B) Alignment of 3′-terminal of S genes of CCoV and FCoV strains. </plain></SENT>
<SENT sid="292" pm="."><plain>Square indicates conserved region. </plain></SENT>
<SENT sid="293" pm="."><plain>Nucleotide sequences originating from type II CCoV and type I FCoV are shown in blue and red, respectively. </plain></SENT>
<SENT sid="294" pm="."><plain>Dots indicate the same sequences with type II CCoV fc1. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0106534.g004"/></fig></SecTag><p><text><SENT sid="295" pm="."><plain>The alignment data using type I FCoV C3663, type II FCoV M91-267, KUK-H/L and Tokyo/cat/130627, and type II CCoV fc1 showed that the recombination site of Tokyo/cat/130627 was in the 3′-terminal of the S gene. </plain></SENT>
<SENT sid="296" pm="."><plain>Among these FCoVs and CCoVs, region 4183–4202 of the S gene was completely conserved (Fig. 4B). </plain></SENT>
<SENT sid="297" pm="."><plain>Upstream of the conserved region, Tokyo/cat/130627 was more similar to type II CCoV fc1 than type I FCoV C3663, and downstream of the conserved region, Tokyo/cat/130627 was more similar to type I FCoV C3663 (Fig. 4B). </plain></SENT>
</text></p></sec><sec id="s3f"><title><text><SENT sid="298" pm="."><plain>Cross-neutralization activity to CCoV by sera collected from cats infected with FCoV </plain></SENT>
</text></title><p><text><SENT sid="299" pm="."><plain>In order to examine whether cats with VN antibody against type I FCoV can be infected with type II CCoV, cross-neutralizing activity of sera from cats experimentally infected with FCoVs was examined (Table 1). </plain></SENT>
<SENT sid="300" pm="."><plain>Cat serum against type I FCoV C3663 was able to neutralize infection of type I FCoV strains C3663 and Yayoi (1∶6400 and 1∶2000, respectively), but not those of type II CCoV and type II FCoV (less than 1∶10) (Table1). </plain></SENT>
<SENT sid="301" pm="."><plain>On the other hand, cat serum against type II FCoV M91-267 was able to neutralize infection of type II FCoV (1∶6400–1∶25600), CCoV (1∶200–1∶9051) and type I FCoV (1∶80–1∶160) (Table1). </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="s4"><title><text><SENT sid="302" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="303" pm="."><plain>Type II FCoV emerged as a result of recombination events between type I FCoV and type II CCoV [44], [45]. </plain></SENT>
<SENT sid="304" pm="."><plain>Recently, one additional full genome sequence of type II FCoV NTU156/P/2007 was determined, and this facilitated understanding of the mechanisms responsible for emergence of type II FCoV [46]. </plain></SENT>
<SENT sid="305" pm="."><plain>The prevalence of type II FCoV in the cat population is lower than that of type I, but the reasons for this remain uncertain [12], [47]–[51]. </plain></SENT>
<SENT sid="306" pm="."><plain>In this study, numerous FCoV and CCoV isolates from Japan were genetically characterized, and the emergence of type II was discussed. </plain></SENT>
</text></p><p><text><SENT sid="307" pm="."><plain>Our phylogenetic and sequence analysis clearly indicated that type II FCoVs emerged by different recombination events between type I FCoV and type II CCoV. </plain></SENT>
<SENT sid="308" pm="."><plain>In addition, other type II FCoVs isolated from the USA (79–1683 and 79–1146) and Chinese Taipei (NTU156/P/2007) also showed different origins [45], [46]. </plain></SENT>
<SENT sid="309" pm="."><plain>These results indicate that type II FCoV independently emerged in different cats and did not spread very easily. </plain></SENT>
<SENT sid="310" pm="."><plain>Our previous study also showed that many cats possess VN antibody to type I FCoV, but few cats in Japan possess VN antibody against type II FCoV [12], supporting the notion that type II FCoV does not readily spread among the cat population. </plain></SENT>
<SENT sid="311" pm="."><plain>The reasons why type II FCoV is unable to spread among the cat population are unclear. </plain></SENT>
</text></p><p><text><SENT sid="312" pm="."><plain>Two of three stains of Japanese type II FCoV, M91-267 and Tokyo/cat/130627, possessed the truncated ORF 3c gene (Fig. 1). </plain></SENT>
<SENT sid="313" pm="."><plain>An intact 3c gene is apparently essential for efficient replication of FCoV in the intestinal tract, resulting in the secretion of FCoV from feces and transmission of FCoV among cat population [55], [56]. </plain></SENT>
<SENT sid="314" pm="."><plain>On the other hand, many FIPV possessed truncated 3c gene and cats with FIP did not excrete virus in feces [57]–[59]. </plain></SENT>
<SENT sid="315" pm="."><plain>Furthermore, one outbreak of type II FIPV with intact ORF 3c gene occurred in Taiwan. </plain></SENT>
<SENT sid="316" pm="."><plain>In early stages of the outbreak, the type II FIPV possessed intact 3c gene, but lost it in later stages [60]. </plain></SENT>
<SENT sid="317" pm="."><plain>Therefore, these type II FCoVs with truncated 3c gene, M91-267 and Tokyo/cat/130627, might not spread well among cats. </plain></SENT>
</text></p><p><text><SENT sid="318" pm="."><plain>It is interesting that all FCoVs, both types I and II, possessed the 5′- and 3′-termini of the FCoV genome, but not CCoV. </plain></SENT>
<SENT sid="319" pm="."><plain>These regions may be essential for growth of FCoV in cats and double recombination may be required to maintain both the 5′- and 3′-termini of FCoV. </plain></SENT>
<SENT sid="320" pm="."><plain>Type II FCoVs possessed two types of RdRp element derived from type I FCoV or type II CCoV (Fig. 2A), suggesting both types of RdRp were able to function during replication and transcription in cat body. </plain></SENT>
<SENT sid="321" pm="."><plain>Furthermore, the region upstream of RdRp might be essential for FCoV infection in cats. </plain></SENT>
<SENT sid="322" pm="."><plain>In addition, it has been reported that N protein is important for viral particle production [52], and the N gene is conserved among FCoVs. </plain></SENT>
<SENT sid="323" pm="."><plain>Therefore, the N protein of FCoV, but not CCoV, may be essential for replication of FCoV in cats. </plain></SENT>
<SENT sid="324" pm="."><plain>Interestingly, simplot analysis showed four other candidate recombination sites, one in the 3c gene, two in the N gene and one in the 7a gene, which showed high identity between CCoV and type I FCoV (Fig. 3). </plain></SENT>
<SENT sid="325" pm="."><plain>If the M or N genes of type I FCoV are not necessary for growth of FCoV in cats, other recombinant type II FCoVs using these possible recombination sites must occur. </plain></SENT>
<SENT sid="326" pm="."><plain>Further analysis of type II FCoV is necessary to clarify the recombination events of CoV in cats. </plain></SENT>
</text></p><p><text><SENT sid="327" pm="."><plain>Four full genome sequences of type II FCoVs (79–1146, 79–1683, DF-2 and NTU156/P/2007) are deposited in GenBank. </plain></SENT>
<SENT sid="328" pm="."><plain>We also reported one-third of the full genome of three type II FCoV strains (M91-267, KUK-H/L and Tokyo/cat/130627) and one type II CCoV fc1. </plain></SENT>
<SENT sid="329" pm="."><plain>Six of seven type II FCoV strains emerged by recombination events at the E or M gene. </plain></SENT>
<SENT sid="330" pm="."><plain>However, the recombination event of Tokyo/cat/130627 occurred at the 3′-terminal of the S gene. </plain></SENT>
<SENT sid="331" pm="."><plain>The nucleotide sequences indicated that M91-267, KUK-H/L and Tokyo/cat/130627 originated from type I FCoV strains similar to C3663, Yayoi and NTU2/R/2003, respectively, and that the central region, including the S gene, was acquired from type II CCoV strains similar to fc94-039, fc1 and fc00-089, respectively. </plain></SENT>
<SENT sid="332" pm="."><plain>In addition, the recombination sites were clearly different (Fig.3 and 4A, B). </plain></SENT>
<SENT sid="333" pm="."><plain>These results indicate that the recombination events between type I FCoV and type II CCoV occurred independently. </plain></SENT>
<SENT sid="334" pm="."><plain>In addition, original viruses of foreign type II FCoVs, 79-1146, 79-1683 and NTU156/P/2007 differed from those of these three Japanese type II FCoVs, indicating that the recombination events occurred among cat populations all over the world. </plain></SENT>
</text></p><p><text><SENT sid="335" pm="."><plain>Sera from cats experimentally inoculated with type I FCoV C3663 could not neutralize type II CCoV infection (Table 1), thus suggesting that the cat infected with type I FCoV could not prevent type II FCoV infection. </plain></SENT>
<SENT sid="336" pm="."><plain>On the other hand, the cat infected with type II FCoV could neutralize type I FCoV infection (Table 1). </plain></SENT>
<SENT sid="337" pm="."><plain>In addition, many sera from type II FCoV-infected cats in the outbreak could cross-neutralize type I FCoV infection, and those from type I FCoV-infected cats in the field could not cross-neutralize type II FCoV infection (our unpublished data). </plain></SENT>
<SENT sid="338" pm="."><plain>These results suggest that the cross-reactivity to type I FCoV in type II FCoV-infected cats might be induced by viral proteins other than S protein. </plain></SENT>
<SENT sid="339" pm="."><plain>Further analysis will be required to clarify the cross VN activity in type II FCoV-infected cats. </plain></SENT>
</text></p><p><text><SENT sid="340" pm="."><plain>Type II CCoV was able to use “feline” aminopeptidase N as a receptor to infect cats [53], [54] and type I FCoV-infected cats did not possess VN antibody against type II CCoV infection (Table 1), indicating that cats infected with type I FCoV could be superinfected with type II CCoV from dogs. </plain></SENT>
<SENT sid="341" pm="."><plain>Our hypothesis on the mechanism of emergence of type II FCoV is shown in Fig. 5. </plain></SENT>
<SENT sid="342" pm="."><plain>Cats infected with type I FCoV were unable to produce VN antibody against type II CCoV. </plain></SENT>
<SENT sid="343" pm="."><plain>Hence, cats had the possibility of superinfection with type II CCoV. </plain></SENT>
<SENT sid="344" pm="."><plain>The recombination event between type I FCoV and type II CCoV occurred inside the cat body, leading to emergence of type II FCoV. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0106534-g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0106534.g005</object-id><label>Figure 5</label><caption><title><text><SENT sid="345" pm="."><plain>Hypothesis of emergence of type II FCoV. </plain></SENT>
</text></title><p><text><SENT sid="346" pm="."><plain>Some cats persistently infected with type I FCoV are superinfected with type II CCoV which is excreted from dogs. </plain></SENT>
<SENT sid="347" pm="."><plain>Inside the cat body, type II FCoV emerges by homologous recombination and induces severe clinical disease, FIP. </plain></SENT>
<SENT sid="348" pm="."><plain>Diseased cats do not spread type II FCoV. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0106534.g005"/></fig></SecTag><p><text><SENT sid="349" pm="."><plain>CoVs, such as SARS-CoV, tend to change their host range by mutation and/or recombination [61]. </plain></SENT>
<SENT sid="350" pm="."><plain>Homologous recombination is a significant factor for change of host range. </plain></SENT>
<SENT sid="351" pm="."><plain>Therefore, investigations into homologous recombination of CoVs may help to clarify the mechanisms responsible for changes in host range. </plain></SENT>
</text></p></sec></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material" id="s5"><title><text><SENT sid="352" pm="."><plain>Supporting Information </plain></SENT>
</text></title><supplementary-material content-type="local-data" id="pone.0106534.s001"><label>Table S1</label><caption><p><text><SENT sid="353" pm="."><plain>Primers used in this study. </plain></SENT>
</text></p><p><text><SENT sid="354" pm="."><plain>(DOCX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0106534.s001.docx"><caption><p><text><SENT sid="355" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0106534.s002"><label>Table S2</label><caption><p><text><SENT sid="356" pm="."><plain>Comparison of ORF identities between C3663 and other coronaviruses. </plain></SENT>
</text></p><p><text><SENT sid="357" pm="."><plain>(DOCX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0106534.s002.docx"><caption><p><text><SENT sid="358" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0106534.s003"><label>Table S3</label><caption><p><text><SENT sid="359" pm="."><plain>Comparison of ORF identities between fc1 and other coronaviruses. </plain></SENT>
</text></p><p><text><SENT sid="360" pm="."><plain>(DOCX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0106534.s003.docx"><caption><p><text><SENT sid="361" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0106534.s004"><label>Table S4</label><caption><p><text><SENT sid="362" pm="."><plain>Amino acid sequence identities of partial RdRp among type II CCoV and types I and II FCoV. </plain></SENT>
</text></p><p><text><SENT sid="363" pm="."><plain>(DOCX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0106534.s004.docx"><caption><p><text><SENT sid="364" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0106534.s005"><label>Table S5</label><caption><p><text><SENT sid="365" pm="."><plain>Amino acid sequence identities of partial S protein among type II CCoV and types I and II FCoV. </plain></SENT>
</text></p><p><text><SENT sid="366" pm="."><plain>(DOCX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0106534.s005.docx"><caption><p><text><SENT sid="367" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0106534.s006"><label>Table S6</label><caption><p><text><SENT sid="368" pm="."><plain>Amino acid sequence identities of N protein among type II CCoV and types I and II FCoV. </plain></SENT>
</text></p><p><text><SENT sid="369" pm="."><plain>(DOCX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0106534.s006.docx"><caption><p><text><SENT sid="370" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></sec></SecTag></body><back><SecTag type="REF"><ref-list><title>References</title><ref id="pone.0106534-Woo1"><text><SENT sid="371" pm="."><plain>1 WooPC, HuangY, LauSK, YuenKY (2010) Coronavirus genomics and bioinformatics analysis. Viruses 2: 1804–1820.21994708 </plain></SENT>
</text></ref><ref id="pone.0106534-Makino1"><text><SENT sid="372" pm="."><plain>2 MakinoS, JooM, MakinoJK (1991) A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J Virol 65: 6031–6041.1656085 </plain></SENT>
</text></ref><ref id="pone.0106534-Pasternak1"><text><SENT sid="373" pm="."><plain>3 PasternakAO, SpaanWJ, SnijderEJ (2006) Nidovirus transcription: how to make sense…? J Gen Virol 87: 1403–1421.16690906 </plain></SENT>
</text></ref><ref id="pone.0106534-Bolles1"><text><SENT sid="374" pm="."><plain>4 BollesM, DonaldsonE, BaricR (2011) SARS-CoV and Emergent Coronaviruses: Viral Determinants of Interspecies Transmission. Curr Opin Virol 1: 624–634.22180768 </plain></SENT>
</text></ref><ref id="pone.0106534-Eckerle1"><text><SENT sid="375" pm="."><plain>5 EckerleLD, BeckerMM, HalpinRA, LiK, VenterE, et al (2010) Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog 6: e1000896.20463816 </plain></SENT>
</text></ref><ref id="pone.0106534-Lai1"><text><SENT sid="376" pm="."><plain>6 LaiMM, BaricRS, MakinoS, KeckJG, EgbertJ, et al (1985) Recombination between nonsegmented RNA genomes of murine coronaviruses. J Virol 56: 449–456.2997467 </plain></SENT>
</text></ref><ref id="pone.0106534-Luytjes1"><text><SENT sid="377" pm="."><plain>7 LuytjesW, BredenbeekPJ, NotenAF, HorzinekMC, SpaanWJ (1988) Sequence of mouse hepatitis virus A59 mRNA 2: indications for RNA recombination between coronaviruses and influenza C virus. Virology 166: 415–422.2845655 </plain></SENT>
</text></ref><ref id="pone.0106534-Zeng1"><text><SENT sid="378" pm="."><plain>8 ZengQ, LangereisMA, van VlietAL, HuizingaEG, et al (2008) Structure of coronavirus hemagglutinin-esterase offers insight into corona and influenza virus evolution. Proc Natl Acad Sci U S A 105: 9065–9069.18550812 </plain></SENT>
</text></ref><ref id="pone.0106534-Pedersen1"><text><SENT sid="379" pm="."><plain>9 PedersenNC, EvermannJF, McKeirnanAJ, OttRL (1984) Pathogenicity studies of feline coronavirus isolates 79–1146 and 79–1683. Am J Vet Res 45: 2580–2585.6084432 </plain></SENT>
</text></ref><ref id="pone.0106534-Fiscus1"><text><SENT sid="380" pm="."><plain>10 FiscusSA, TeramotoYA (1987) Antigenic comparison of feline coronavirus isolates: evidence for markedly different peplomer glycoproteins. J Virol 61: 2607–2613.3599183 </plain></SENT>
</text></ref><ref id="pone.0106534-Hohdatsu1"><text><SENT sid="381" pm="."><plain>11 HohdatsuT, SasamotoT, OkadaS, KoyamaH (1991) Antigenic analysis of feline coronaviruses with monoclonal antibodies (MAbs): preparation of MAbs which discriminate between FIPV strain 79–1146 and FECV strain 79–1683. Vet Microbiol 28: 13–24.1653482 </plain></SENT>
</text></ref><ref id="pone.0106534-Shiba1"><text><SENT sid="382" pm="."><plain>12 ShibaN, MaedaK, KatoH, MochizukiM, IwataH (2007) Differentiation of feline coronavirus type I and II infections by virus neutralization test. Vet Microbiol 124: 348–352.17543480 </plain></SENT>
</text></ref><ref id="pone.0106534-Hohdatsu2"><text><SENT sid="383" pm="."><plain>13 HohdatsuT, IzumiyaY, YokoyamaY, KidaK, KoyamaH (1998) Differences in virus receptor for type I and type II feline infectious peritonitis virus. Arch Virol 143: 839–850.9645192 </plain></SENT>
</text></ref><ref id="pone.0106534-Tekes1"><text><SENT sid="384" pm="."><plain>14 TekesG, Hofmann-LehmannR, Bank-WolfB, MaierR, ThielHJ, et al (2010) Chimeric feline coronaviruses that encode type II spike protein on type I genetic background display accelerated viral growth and altered receptor usage. J Virol 84: 1326–1333.19906918 </plain></SENT>
</text></ref><ref id="pone.0106534-Binn1"><text><SENT sid="385" pm="."><plain>15 BinnLN, LazarEC, KeenanKP, HuxsollDL, MarchwickiRH, et al (1974) Recovery and characterization of a coronavirus from military dogs with diarrhea. Proc Annu Meet U.S. </plain></SENT>
<SENT sid="386" pm="."><plain>Anim Health Assoc 78: 359–366. </plain></SENT>
</text></ref><ref id="pone.0106534-Carmichael1"><text><SENT sid="387" pm="."><plain>16Carmichael LE (1978) Infectious canine enteritis caused by corona-like virus: current status and request for information. </plain></SENT>
<SENT sid="388" pm="."><plain>Baker Institute Laboratory Report, series 2, no. 9. </plain></SENT>
<SENT sid="389" pm="."><plain>James A. Baker Institute for Animal Health, Ithaca, N.Y. </plain></SENT>
</text></ref><ref id="pone.0106534-Rimmelzwaan1"><text><SENT sid="391" pm="."><plain>17 RimmelzwaanGF, GroenJ, EgberinkH, BorstGH, Uytde- HaagFG, et al (1991) The use of enzyme-linked immunosorbent assay systems for serology and antigen detec- tion in parvovirus, coronavirus and rotavirus infections in dogs in The Netherlands. </plain></SENT>
<SENT sid="392" pm="."><plain>Vet. Microbiol 26: 25–40. </plain></SENT>
</text></ref><ref id="pone.0106534-Tennant1"><text><SENT sid="393" pm="."><plain>18 TennantBJ, GaskellRM, JonesRC, GaskellCJ (1993) Studies on the epizootiology of canine coronavirus. Vet Rec 132: 7–11.8382389 </plain></SENT>
</text></ref><ref id="pone.0106534-Bandai1"><text><SENT sid="394" pm="."><plain>19 BandaiC, IshiguroS, MasuyaN, HohdatsuT, MochizukiM (1999) Canine coronavirus infections in Japan: virological and epidemiological aspects. J Vet Med Sci 61: 731–736.10458093 </plain></SENT>
</text></ref><ref id="pone.0106534-Naylor1"><text><SENT sid="395" pm="."><plain>20 NaylorMJ, MoncktonRP, LehrbachPR, DeaneEM (2001) Canine coronavirus in Australian dogs. Aust Vet J 79: 116–119.11256282 </plain></SENT>
</text></ref><ref id="pone.0106534-Yeilba1"><text><SENT sid="396" pm="."><plain>21 YeşilbağK, YilmazZ, TorunS, PratelliA (2004) Canine coronavirus infection in Turkish dog population. J Vet Med B Infect Dis Vet Public Health 51: 353–355.15525364 </plain></SENT>
</text></ref><ref id="pone.0106534-Schulz1"><text><SENT sid="397" pm="."><plain>22 SchulzBS, StrauchC, MuellerRS, EichhornW, HartmannK (2008) Comparison of the prevalence of enteric viruses in healthy dogs and those with acute haemorrhagic diarrhoea by electron microscopy. J. Small Anim. </plain></SENT>
<SENT sid="399" pm="."><plain>Pract 49: 84–88.18086157 </plain></SENT>
</text></ref><ref id="pone.0106534-Pratelli1"><text><SENT sid="400" pm="."><plain>23 PratelliA, MartellaV, DecaroN, TinelliA, CameroM, et al (2003) Genetic diversity of a canine coronavirus detected in pups with diarrhoea in Italy. J Virol Methods 110: 9–17.12757915 </plain></SENT>
</text></ref><ref id="pone.0106534-Lorusso1"><text><SENT sid="401" pm="."><plain>24 LorussoA, DecaroN, SchellenP, RottierPJ, BuonavogliaC, et al (2008) Gain, preservation, and loss of a group 1a coronavirus accessory glycoprotein. J Virol 82: 10312–10317.18667517 </plain></SENT>
</text></ref><ref id="pone.0106534-Pratelli2"><text><SENT sid="402" pm="."><plain>25 PratelliA, DecaroN, TinelliA, MartellaV, EliaG, et al (2004) Two genotypes of canine coronavirus simultaneously detected in the fecal samples of dogs with diarrhea. J Clin Microbiol 42: 1797–1799.15071054 </plain></SENT>
</text></ref><ref id="pone.0106534-Decaro1"><text><SENT sid="403" pm="."><plain>26 DecaroN, MariV, EliaG, AddieDD, CameroM, et al (2010) Recombinant canine coronaviruses in dogs, Europe. Emerg Infect Dis 16: 41–47.20031041 </plain></SENT>
</text></ref><ref id="pone.0106534-Soma1"><text><SENT sid="404" pm="."><plain>27 SomaT, OhinataT, IshiiH, TakahashiT, TaharaguchiS, et al (2011) Detection and genotyping of canine coronavirus RNA in diarrheic dogs in Japan. Res Vet Sci 90: 205–207.20557915 </plain></SENT>
</text></ref><ref id="pone.0106534-Decaro2"><text><SENT sid="405" pm="."><plain>28 DecaroN, MariV, CampoloM, LorussoA, CameroM, et al (2009) Recombinant canine coronaviruses related to transmissible gastroenteritis virus of Swine are circulating in dogs. J Virol 83: 1532–1527.19036814 </plain></SENT>
</text></ref><ref id="pone.0106534-Buonavoglia1"><text><SENT sid="406" pm="."><plain>29 BuonavogliaC, DecaroN, MartellaV, EliaG, CampoloM, et al (2006) Canine coronavirus highly pathogenic for dogs. Emerg Infect Dis 12: 492–494.16704791 </plain></SENT>
</text></ref><ref id="pone.0106534-Decaro3"><text><SENT sid="407" pm="."><plain>30 DecaroN, BuonavogliaC (2008) An update on canine coronaviruses: viral evolution and pathobiology. Vet Microbiol 132: 221–234.18635322 </plain></SENT>
</text></ref><ref id="pone.0106534-Decaro4"><text><SENT sid="408" pm="."><plain>31 DecaroN, EliaG, MartellaV, CampoloM, MariV, et al (2010) Immunity after natural exposure to enteric canine coronavirus does not provide complete protection against infection with the new pantropic CB/05 strain. Vaccine 28: 724–729.19887130 </plain></SENT>
</text></ref><ref id="pone.0106534-JacobseGeels1"><text><SENT sid="409" pm="."><plain>32 Jacobse-GeelsHE, HorzinekMC (1983) Expression of feline infectious peritonitis coronavirus antigens on the surface of feline macrophage-like cells. J Gen Virol 64: 1859–1866.6886678 </plain></SENT>
</text></ref><ref id="pone.0106534-Hohdatsu3"><text><SENT sid="410" pm="."><plain>33 HohdatsuT, OkadaS, KoyamaH (1991) Characterization of monoclonal antibodies against feline infectious peritonitis virus type II and antigenic relationship between feline, porcine, and canine coronaviruses. Arch Virol 117: 85–95.1706593 </plain></SENT>
</text></ref><ref id="pone.0106534-Hayashi1"><text><SENT sid="411" pm="."><plain>34 HayashiT, YanaiT, TsurudomeM, NakayamaH, WatabeY, et al (1981) Serodiagnosis for feline infectious peritonitis by immunofluorescence using infected suckling mouse brain sections. J Vet Med Sci 43: 669–676. </plain></SENT>
</text></ref><ref id="pone.0106534-Mochizuki1"><text><SENT sid="412" pm="."><plain>35 MochizukiM, MitsutakeY, MiyanoharaY, HigashiharaT, ShimizuT, et al (1997) Antigenic and plaque variations of serotype II feline infectious peritonitis coronaviruses. J Vet Med Sci 59: 253–258.9152932 </plain></SENT>
</text></ref><ref id="pone.0106534-Terada1"><text><SENT sid="413" pm="."><plain>36 TeradaY, ShiozakiY, ShimodaH, MahmoudHY, NoguchiK, et al (2012) Feline infectious peritonitis virus with a large deletion in the 5' terminal region of spike gene retains its virulence for cats. J Gen Virol 93: 1930–1934.22718568 </plain></SENT>
</text></ref><ref id="pone.0106534-Mochizuki2"><text><SENT sid="414" pm="."><plain>37 MochizukiM, HashimotoM, IshidaT (2001) Recent epidemiological status of canine viral enteric infections and Giardia infection in Japan. J Vet Med Sci 63: 573–575.11411507 </plain></SENT>
</text></ref><ref id="pone.0106534-Naylor2"><text><SENT sid="415" pm="."><plain>38 NaylorMJ, WaliaCS, McOristS, LehrbachPR, DeaneEM, et al (2002) Molecular characterization confirms the presence of a divergent strain of canine coronavirus (UWSMN-1) in Australia. J Clin Microbiol 40: 3518–3522.12202609 </plain></SENT>
</text></ref><ref id="pone.0106534-Wang1"><text><SENT sid="416" pm="."><plain>39 WangYY, LuCP (2009) Analysis of putative recombination hot sites in the S gene of canine coronaviruses. Acta Virol 53: 111–112.19537912 </plain></SENT>
</text></ref><ref id="pone.0106534-Terada2"><text><SENT sid="417" pm="."><plain>40 TeradaY, MinamiS, NoguchiK, MahmoudHY, ShimodaH, et al (2014) Genetic characterization of coronaviruses from domestic ferrets, Japan. Emerg Infect Dis 20: 284–287.24447852 </plain></SENT>
</text></ref><ref id="pone.0106534-Saitou1"><text><SENT sid="418" pm="."><plain>41 SaitouN, NeiM (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4: 406–425.3447015 </plain></SENT>
</text></ref><ref id="pone.0106534-Tamura1"><text><SENT sid="419" pm="."><plain>42 TamuraK, PetersonD, PetersonN, StecherG, NeiM, et al (2011) MEGA5: Molecular Evolutionary Genetics Analysis using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony Methods. Mol Biol Evol 28: 2731–2739.21546353 </plain></SENT>
</text></ref><ref id="pone.0106534-Lole1"><text><SENT sid="420" pm="."><plain>43 LoleKS, BollingerRC, ParanjapeRS, GadkariD, KulkarniSS, et al (1999) Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73: 152–160.9847317 </plain></SENT>
</text></ref><ref id="pone.0106534-Motokawa1"><text><SENT sid="421" pm="."><plain>44 MotokawaK, HohdatsuT, HashimotoH, KoyamaH, et al (1996) Comparison of the amino acid sequence and phylogenetic analysis of the peplomer, integral membrane and nucleocapsid proteins of feline, canine and porcine coronaviruses. Microbiol Immunol 40: 425–433.8839428 </plain></SENT>
</text></ref><ref id="pone.0106534-Herrewegh1"><text><SENT sid="422" pm="."><plain>45 HerreweghAA, SmeenkI, HorzinekMC, RottierPJ, de GrootRJ (1998) Feline coronavirus type II strains 79–1683 and 79–1146 originate from a double recombination between feline coronavirus type I and canine coronavirus. J Virol 72: 4508–514.9557750 </plain></SENT>
</text></ref><ref id="pone.0106534-Lin1"><text><SENT sid="423" pm="."><plain>46 LinCN, ChangRY, SuBL, ChuehLL (2013) Full genome analysis of a novel type II feline coronavirus NTU156. Virus Genes 46: 316–322.23239278 </plain></SENT>
</text></ref><ref id="pone.0106534-Vennema1"><text><SENT sid="424" pm="."><plain>47 VennemaH (1999) Genetic drift and genetic shift during feline coronavirus evolution. Vet Microbiol 69: 139–141.10515284 </plain></SENT>
</text></ref><ref id="pone.0106534-Addie1"><text><SENT sid="425" pm="."><plain>48 AddieDD, SchaapIA, NicolsonL, JarrettO (2003) Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol 84: 2735–2744.13679608 </plain></SENT>
</text></ref><ref id="pone.0106534-Benetka1"><text><SENT sid="426" pm="."><plain>49 BenetkaV, Kübber-HeissA, KolodziejekJ, NowotnyN, Hofmann-ParisotM, et al (2004) Prevalence of feline coronavirus types I and II in cats with histopathologically verified feline infectious peritonitis. Vet Microbiol 99: 31–42.15019109 </plain></SENT>
</text></ref><ref id="pone.0106534-Kummrow1"><text><SENT sid="427" pm="."><plain>50 KummrowM, MeliML, HaessigM, GoencziE, PolandA, et al (2005) Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland. Clin Diagn Lab Immunol 12: 1209–1215.16210485 </plain></SENT>
</text></ref><ref id="pone.0106534-Hohdatsu4"><text><SENT sid="428" pm="."><plain>51 HohdatsuT, OkadaS, IshizukaY, YamadaH, KoyamaH (1992) The prevalence of types I and II feline coronavirus infections in cats. J Vet Med Sci 54: 557–562.1322718 </plain></SENT>
</text></ref><ref id="pone.0106534-Masters1"><text><SENT sid="429" pm="."><plain>52 MastersPS (2006) The molecular biology of coronaviruses. Adv Virus Res 66: 193–292.16877062 </plain></SENT>
</text></ref><ref id="pone.0106534-Tresnan1"><text><SENT sid="430" pm="."><plain>53 TresnanDB, LevisR, HolmesKV (1996) Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. J Virol 70: 8669–8674.8970993 </plain></SENT>
</text></ref><ref id="pone.0106534-McArdle1"><text><SENT sid="431" pm="."><plain>54 McArdleF, BennettM, GaskellRM, TennantB, KellyDF, et al (1990) Canine coronavirus infection in cats; a possible role in feline infectious peritonitis. Adv Exp Med Biol 276: 475–479.1966440 </plain></SENT>
</text></ref><ref id="pone.0106534-Pedersen2"><text><SENT sid="432" pm="."><plain>55 PedersenNC (2009) A review of feline infectious peritonitis virus infection: 1963–2008. J Feline Med Surg 11: 225–258.19254859 </plain></SENT>
</text></ref><ref id="pone.0106534-Pedersen3"><text><SENT sid="433" pm="."><plain>56 PedersenNC, LiuH, ScarlettJ, LeuteneggerCM, GolovkoL, et al (2012) Feline infectious peritonitis: role of the feline coronavirus 3c gene in intestinal tropism and pathogenicity based upon isolates from resident and adopted shelter cats. Virus Res.165: 17–28.22280883 </plain></SENT>
</text></ref><ref id="pone.0106534-Chang1"><text><SENT sid="434" pm="."><plain>57 ChangHW, de GrootRJ, EgberinkHF, RottierPJ (2010) Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene. J Gen Virol 91: 415–420.19889934 </plain></SENT>
</text></ref><ref id="pone.0106534-Vennema2"><text><SENT sid="435" pm="."><plain>58 VennemaH, PolandA, FoleyJ, PedersenNC (1998) Feline infectious peritonitis viruses arise by mutation from endemic feline enteric coronaviruses. Virology 243: 150–157.9527924 </plain></SENT>
</text></ref><ref id="pone.0106534-Pedersen4"><text><SENT sid="436" pm="."><plain>59 PedersenNC, LiuH, DoddKA, PesaventoPA (2009) Significance of coronavirus mutants in feces and diseased tissues of cats suffering from feline infectious peritonitis. Viruses 1: 166–184.21994544 </plain></SENT>
</text></ref><ref id="pone.0106534-Wang2"><text><SENT sid="437" pm="."><plain>60 WangYT, SuBL, HsiehLE, ChuehLL (2013) An outbreak of feline infectious peritonitis in a Taiwanese shelter: epidemiologic and molecular evidence for horizontal transmission of a novel type II feline coronavirus. Vet Res 44: 57.23865689 </plain></SENT>
</text></ref><ref id="pone.0106534-Graham1"><text><SENT sid="438" pm="."><plain>61 GrahamRL, BaricRS (2010) Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission. J Virol 84: 3134–3146.19906932 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
